Literature DB >> 15946649

Generation of skeletal muscle from transplanted embryonic stem cells in dystrophic mice.

Satyakam Bhagavati1, Weimin Xu.   

Abstract

Embryonic stem (ES) cells have great therapeutic potential because of their capacity to proliferate extensively and to form any fully differentiated cell of the body, including skeletal muscle cells. Successful generation of skeletal muscle in vivo, however, requires selective induction of the skeletal muscle lineage in cultures of ES cells and following transplantation, integration of appropriately differentiated skeletal muscle cells with recipient muscle. Duchenne muscular dystrophy (DMD), a severe progressive muscle wasting disease due to a mutation in the dystrophin gene and the mdx mouse, an animal model for DMD, are characterized by the absence of the muscle membrane associated protein, dystrophin. Here, we show that co-culturing mouse ES cells with a preparation from mouse muscle enriched for myogenic stem and precursor cells, followed by injection into mdx mice, results occasionally in the formation of normal, vascularized skeletal muscle derived from the transplanted ES cells. Study of this phenomenon should provide valuable insights into skeletal muscle development in vivo from transplanted ES cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15946649     DOI: 10.1016/j.bbrc.2005.05.135

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  The therapeutic potential of embryonic and adult stem cells for skeletal muscle regeneration.

Authors:  Radbod Darabi; Filipe N C Santos; Rita C R Perlingeiro
Journal:  Stem Cell Rev       Date:  2008-07-08       Impact factor: 5.739

Review 2.  Satellite cells and the muscle stem cell niche.

Authors:  Hang Yin; Feodor Price; Michael A Rudnicki
Journal:  Physiol Rev       Date:  2013-01       Impact factor: 37.312

Review 3.  Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells.

Authors:  Francesco Saverio Tedesco; Arianna Dellavalle; Jordi Diaz-Manera; Graziella Messina; Giulio Cossu
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

Review 4.  Stem cells for skeletal muscle regeneration: therapeutic potential and roadblocks.

Authors:  Fabrizio Rinaldi; Rita C R Perlingeiro
Journal:  Transl Res       Date:  2013-11-14       Impact factor: 7.012

5.  Biophysical cues enhance myogenesis of human adipose derived stem/stromal cells.

Authors:  P Yilgor Huri; C A Cook; D L Hutton; B C Goh; J M Gimble; D J DiGirolamo; W L Grayson
Journal:  Biochem Biophys Res Commun       Date:  2013-07-20       Impact factor: 3.575

6.  The potential of stem cells in the treatment of skeletal muscle injury and disease.

Authors:  S Maclean; W S Khan; A A Malik; S Anand; M Snow
Journal:  Stem Cells Int       Date:  2011-12-19       Impact factor: 5.443

Review 7.  Molecular and cell-based therapies for muscle degenerations: a road under construction.

Authors:  Emanuele Berardi; Daniela Annibali; Marco Cassano; Stefania Crippa; Maurilio Sampaolesi
Journal:  Front Physiol       Date:  2014-04-08       Impact factor: 4.566

8.  Sources for skeletal muscle repair: from satellite cells to reprogramming.

Authors:  Dario Sirabella; Luciana De Angelis; Libera Berghella
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-01-12       Impact factor: 12.910

9.  Transplantated mesenchymal stem cells derived from embryonic stem cells promote muscle regeneration and accelerate functional recovery of injured skeletal muscle.

Authors:  Nana Takenaka Ninagawa; Eri Isobe; Yuri Hirayama; Rumi Murakami; Kazumi Komatsu; Masataka Nagai; Mami Kobayashi; Yuka Kawabata; Shigeko Torihashi
Journal:  Biores Open Access       Date:  2013-08

10.  Directed in vitro myogenesis of human embryonic stem cells and their in vivo engraftment.

Authors:  Yongsung Hwang; Samuel Suk; Susan Lin; Matthew Tierney; Bin Du; Timothy Seo; Aaron Mitchell; Alessandra Sacco; Shyni Varghese
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.